Godspower Akpomiemie

Johannesburg, GT, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Initial HIV Therapy for Adults and Treatment-Associated Weight Gain: The Opti-DOR Randomized Clinical Trial.

Initial HIV Therapy for Adults and Treatment-Associated Weight Gain: The Opti-DOR Randomized Clinical Trial.

Journal: JAMA

Published: July 31, 2026

Pulmonary manifestations of long COVID in Johannesburg, South Africa.

Pulmonary manifestations of long COVID in Johannesburg, South Africa.

Journal: Southern African journal of infectious diseases

Published: March 26, 2025

Pharmacokinetics, pharmacogenetics, and toxicity of co-administered efavirenz and isoniazid.

Pharmacokinetics, pharmacogenetics, and toxicity of co-administered efavirenz and isoniazid.

Journal: Southern African journal of HIV medicine

Published: October 03, 2024

DORA: 48-week weight and metabolic changes in Black women with HIV, in a phase IIIb switch study from dolutegravir- or efavirenz- to doravirine-based first-line antiretroviral therapy.

DORA: 48-week weight and metabolic changes in Black women with HIV, in a phase IIIb switch study from dolutegravir- or efavirenz- to doravirine-based first-line antiretroviral therapy.

Journal: HIV medicine

Published: May 22, 2024

Blood pressure increases are associated with weight gain and not antiretroviral regimen or kidney function: a secondary analysis from the ADVANCE trial in South Africa.

Blood pressure increases are associated with weight gain and not antiretroviral regimen or kidney function: a secondary analysis from the ADVANCE trial in South Africa.

Journal: Journal of the International AIDS Society

Published: December 01, 2023

Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens.

Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens.

Journal: Open forum infectious diseases

Published: August 21, 2023

Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South Africa.

Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South Africa.

Journal: British journal of clinical pharmacology

Published: August 17, 2023

Risks of metabolic syndrome in the ADVANCE and NAMSAL trials.

Risks of metabolic syndrome in the ADVANCE and NAMSAL trials.

Journal: Frontiers in reproductive health

Published: December 29, 2022

Slow and Steady But Not Related to HIV Stigma: Physical Activity in South Africans Living with HIV and Chronic Pain.

Slow and Steady But Not Related to HIV Stigma: Physical Activity in South Africans Living with HIV and Chronic Pain.

Journal: AIDS and behavior

Published: November 06, 2022

Weight and Metabolic Changes After Switching From Tenofovir Alafenamide/Emtricitabine (FTC)+Dolutegravir (DTG), Tenofovir Disoproxil Fumarate (TDF)/FTC + DTG, and TDF/FTC/Efavirenz to TDF/Lamivudine/DTG.

Weight and Metabolic Changes After Switching From Tenofovir Alafenamide/Emtricitabine (FTC)+Dolutegravir (DTG), Tenofovir Disoproxil Fumarate (TDF)/FTC + DTG, and TDF/FTC/Efavirenz to TDF/Lamivudine/DTG.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: October 12, 2022

Comparing Prospective Incident Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates During Successive Waves of Delta and Omicron in Johannesburg, South Africa.

Comparing Prospective Incident Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates During Successive Waves of Delta and Omicron in Johannesburg, South Africa.

Journal: Open forum infectious diseases

Published: August 05, 2022

Pharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African population.

Pharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African population.

Journal: The Journal of antimicrobial chemotherapy

Published: April 20, 2022

Showing 1-12 of 29

Last Updated: 09/26/2026